China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Effects of SGLT2 Inhibitors on Prothrombotic State in Coronary Artery Disease and the Regulation of TRPC3/NCX1 Pathways'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132221
Registration Time: 2026/09/10
Type: Observational study
Primary Sponsor: Shijiazhuang People’s Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322467
Published by HT Digital Content Services with permission from Health Daily Digest....